The role of GDF-15 in heart failure patients with chronic kidney disease
ConclusionIn patients with systolic HF and CKD, GDF-15 is more strongly associated with adverse outcomes than the conventionally used BNP.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Canada Health | Cardiology | Cholesterol | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Heart Failure | Heart Transplant | Kidney Transplant | Kidney Transplantation | Sodium | Study | Transplants | Urology & Nephrology